Journey Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
+6,440
| New | +$2.61M | 0.2% | 109 |
|
|
2025
Q1 | – | Sell |
-387
| Closed | -$214K | – | 289 |
|
|
2024
Q4 | $214K | Hold |
387
| – | – | 0.03% | 219 |
|
|
2024
Q3 | $214K | Hold |
387
| – | – | 0.03% | 219 |
|
|
2024
Q2 | $214K | Hold |
387
| – | – | 0.03% | 218 |
|
|
2024
Q1 | $225K | Hold |
387
| – | – | 0.03% | 221 |
|
|
2023
Q4 | $205K | Buy |
+387
| New | +$205K | 0.03% | 210 |
|
|
2023
Q3 | – | Sell |
-393
| Closed | -$205K | – | 222 |
|
|
2023
Q2 | $205K | Sell |
393
-253
| -39% | -$132K | 0.03% | 219 |
|
|
2023
Q1 | $372K | Sell |
646
-269
| -29% | -$155K | 0.06% | 167 |
|
|
2022
Q4 | $504K | Sell |
915
-36
| -4% | -$19.8K | 0.13% | 126 |
|
|
2022
Q3 | $482K | Buy |
951
+30
| +3% | +$15.2K | 0.12% | 141 |
|
|
2022
Q2 | $543K | Buy |
921
+90
| +11% | +$53.1K | 0.12% | 141 |
|
|
2022
Q1 | $491K | Buy |
831
+11
| +1% | +$6.5K | 0.12% | 136 |
|
|
2021
Q4 | $547K | Buy |
820
+66
| +9% | +$44K | 0.15% | 125 |
|
|
2021
Q3 | $431K | Buy |
754
+35
| +5% | +$20K | 0.14% | 132 |
|
|
2021
Q2 | $363K | Buy |
719
+41
| +6% | +$20.7K | 0.12% | 150 |
|
|
2021
Q1 | $309K | Buy |
678
+39
| +6% | +$17.8K | 0.11% | 149 |
|
|
2020
Q4 | $298K | Buy |
+639
| New | +$298K | 0.11% | 139 |
|